Clinical Trial Update: Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Xeliri plus Avastin followed by Xelox plus Avastin (or reverse sequence) in metastatic colorectal cancer; completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• XELIRI
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Prof. Dr. Werner Scheithauer | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-09-25